KITOZYME
ActiveSummary
KITOZYME has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €17.2m and a net result of €824,661. Equity is growing by ~14% per year across the filed fiscal years. Its solvency ranks better than 81% of 272 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability82▼-2
Solvency100=
Growth64▲+1
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €700,000 at 30 days acceptable
Liquidity ample (current ratio 2.04 against 1.69 in 2024; short-term debt: 16.5% and cash: 2.8% of total assets), and 23.1% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 20
Relative position
BE, all sectors
reference
Manufacture of chemicals and chemical products (NACE 20)
about 43% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
76.9%
Return on assets
3.7%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
29 d early
2024
31 d early
2023
33 d early
2022
497 d late
2021
862 d late
2020
8 d early
2019
21 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 177 days after the deadline; the sector median for financial year 2024 is 22 days before the deadline, and 27% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 2 July (4 of the last 5 filed years within 526 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
In the rankings
#8 company by equity in the province of Liège, Chemicals sector#10 employer in the province of Liège, Chemicals sector#10 company by total assets in the province of Liège, Chemicals sector
Turnover
€7.1m▲ 6.3%
2024 · €6.7m
EBIT margin
9.4%▼ 3.1pp
2024 · 12.5%
Net result
€824,661▼ 24.9%
2024 · €1.1m
Working capital
€3.8m▲ 24.9%
2024 · €3.1m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 20, Manufacture of chemicals and chemical products, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Turnover€5.4m▲ 22.3%€7.7m▲ 43.6%€6.8m▼ 11.1%€6.7m▼ 2.5%€7.1m▲ 6.3%
Operating result€4.9m€1.3m▼ 73.4%€942,436▼ 27.5%€831,719▼ 11.7%€666,147▼ 19.9%
Net result€4.8mabove the sector's middle half€1.5mwithin the sector's middle half▼ 68.2%€1.2mwithin the sector's middle half▼ 19.7%€1.1mwithin the sector's middle half▼ 10.8%€824,661within the sector's middle half▼ 24.9%
EBIT margin91.1%▲ 126.1pp16.9%▼ 74.2pp13.8%▼ 3.1pp12.5%▼ 1.3pp9.4%▼ 3.1pp
Equity€12.4mwithin the sector's middle half▲ 90.6%€13.8mwithin the sector's middle half▲ 11.4%€15.0mwithin the sector's middle half▲ 9.2%€16.0mwithin the sector's middle half▲ 6.5%€17.2mwithin the sector's middle half▲ 7.4%
Total assets€17.8mwithin the sector's middle half▲ 26.0%€18.8mwithin the sector's middle half▲ 5.9%€19.6mwithin the sector's middle half▲ 4.4%€21.0mwithin the sector's middle half▲ 7.3%€22.4mwithin the sector's middle half▲ 6.3%
Debt€5.1m▼ 33.1%€4.8m▼ 5.9%€4.1m▼ 13.3%€4.7m▲ 12.6%€4.8m▲ 3.6%
Working capital€2.7mwithin the sector's middle half▲ 30.9%€3.1mwithin the sector's middle half▲ 14.2%€3.1mwithin the sector's middle half▲ 0.1%€3.1mwithin the sector's middle half▼ 0.1%€3.8mwithin the sector's middle half▲ 24.9%
Solvency69.6%above the sector's middle half▲ 23.6pp73.2%above the sector's middle half▲ 3.6pp76.6%above the sector's middle half▲ 3.4pp76.1%above the sector's middle half▼ 0.5pp76.9%above the sector's middle half▲ 0.8pp
Current ratio1.96within the sector's middle half▲ 0.501.92within the sector's middle half▼ 0.041.89within the sector's middle half▼ 0.031.69within the sector's middle half▼ 0.202.04within the sector's middle half▲ 0.35
Return on assets (ROA)27.2%above the sector's middle half▲ 36.4pp8.2%within the sector's middle half▼ 19.0pp6.3%within the sector's middle half▼ 1.9pp5.2%within the sector's middle half▼ 1.1pp3.7%within the sector's middle half▼ 1.5pp
Staff (FTE)28.6within the sector's middle half▼ 6.8%30.5within the sector's middle half▲ 6.6%28.2within the sector's middle half▼ 7.5%27.3within the sector's middle half▼ 3.2%27.2within the sector's middle half▼ 0.4%
above
within
below
the middle half (P25 to P75) of NACE 20, Manufacture of chemicals and chemical products, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result has fallen four years in a row; 2025 is 20% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €22.4m
Fixed assets
€14.8m ▲ 9.7%
Current assets
€7.5m ▲ 0.2%
Equity and liabilities €22.4m
Equity
€17.2m ▲ 7.4%
Provisions
€326,124 ▼ 9.1%
Debt
€4.8m ▲ 3.6%
Debt's share of the balance-sheet total falls from 22.2% to 21.6%. Equity and debt are higher.
Key figures and ratios
EBITDA
€1.7m▲
2024 · €1.7m
Cash flow
€1.9m▼
2024 · €1.9m
Quick ratio
1.63▲
2024 · 1.33
Debt to equity
0.28▼
2024 · 0.29
ROE
4.8%▼
2024 · 6.9%
Interest coverage
7.96▼
2024 · 10.33
Debt ≤ 1 year
€3.7m▼
2024 · €4.4m
Debt > 1 year
€1.1m▲
2024 · €227,800
Income taxes
-€71,770▼
2024 · €0
Staff costs
€2.8m▲
2024 · €2.6m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 14,733 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 96% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit under 5% of the balance sheet
0.2%
went bankrupt
3.5%
stopped otherwise
96%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 14,733 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | €5.4m | €7.7m | €6.8m | €6.7m | €7.1m | ▲ 6.3% |
| Non-recurring operating income76A | €5.7m | €3,826 | €17,284 | €4,047 | €10,743 | ▲ 165% |
| Goods, raw materials, services and sundry goods60/61 | €2.9m | €4.0m | €4.0m | €3.5m | €3.7m | ▲ 4.4% |
| Remuneration, social security and pensions62 | €2.2m | €2.5m | €2.3m | €2.6m | €2.8m | ▲ 6.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1.4m | €771,534 | €624,054 | €829,126 | €1.1m | ▲ 29.3% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | -€148,551 | €0 | €42,823 | -€17,392 | €131,503 | ▲ 856% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | €58,483 | €3,120 | €284,889 | €599 | -€32,665 | ▼ 5,553% |
| Other operating charges640/8 | €134,207 | €160,982 | €107,966 | €150,458 | €115,194 | ▼ 23.4% |
| Non-recurring operating charges66A | €547,754 | €93,278 | - | €76,650 | €61,855 | ▼ 19.3% |
| Gross operating margin9900 | €9.1m | €4.9m | €4.3m | €4.5m | €4.8m | ▲ 7.1% |
| Operating profit (loss)9901 | €4.9m | €1.3m | €942,436 | €831,719 | €666,147 | ▼ 19.9% |
| Financial income75/76B | €307,051 | €319,033 | €332,094 | €343,573 | €305,197 | ▼ 11.2% |
| Recurring financial income75 | €307,051 | €319,033 | €332,094 | €343,573 | €305,197 | ▼ 11.2% |
| Non-recurring financial income76B | - | €0 | €0 | €0 | €0 | - |
| Financial charges65/66B | €172,440 | €156,544 | €139,498 | €160,731 | €218,453 | ▲ 35.9% |
| Recurring financial charges65 | €172,440 | €156,544 | €139,498 | €160,731 | €218,453 | ▲ 35.9% |
| Non-recurring financial charges66B | - | €0 | €0 | €0 | €0 | - |
| Profit (loss) for the period before taxes9903 | €5.0m | €1.5m | €1.1m | €1.0m | €752,891 | ▼ 25.8% |
| Transfer from deferred taxes780 | - | €70,848 | €95,491 | €82,962 | - | - |
| Transfer to deferred taxes680 | €249,301 | - | - | - | - | - |
| Income taxes67/77 | -€53,706 | - | - | €0 | -€71,770 | - |
| Profit (loss) for the period9904 | €4.8m | €1.5m | €1.2m | €1.1m | €824,661 | ▼ 24.9% |
| Transfer from tax-exempt reserves789 | €40,942 | €212,544 | €286,473 | €248,886 | - | - |
| Transfer to tax-exempt reserves689 | €788,844 | - | - | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €4.1m | €1.7m | €1.5m | €1.3m | €824,661 | ▼ 38.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €17.8m | €18.8m | €19.6m | €21.0m | €22.4m | ▲ 6.3% |
| Formation expenses20 | €0 | €0 | €0 | €0 | €0 | - |
| Fixed assets21/28 | €12.3m | €12.4m | €13.1m | €13.5m | €14.8m | ▲ 9.7% |
| Intangible fixed assets21 | €670,416 | €1.2m | €1.8m | €2.2m | €2.6m | ▲ 17.8% |
| Tangible fixed assets22/27 | €2.1m | €1.7m | €1.8m | €1.9m | €2.0m | ▲ 9.1% |
| Land and buildings22 | €0 | €0 | €876,108 | €795,941 | €715,774 | ▼ 10.1% |
| Plant, machinery and equipment23 | €931,370 | €900,467 | €919,405 | €1.0m | €1.3m | ▲ 24.7% |
| Furniture and vehicles24 | €50,439 | €36,412 | €34,577 | €24,348 | €19,026 | ▼ 21.9% |
| Leasing and similar rights25 | €1.1m | €754,848 | €0 | €0 | €0 | - |
| Other tangible fixed assets26 | €0 | €0 | €0 | €0 | €0 | - |
| Assets under construction and advance payments27 | €0 | €0 | €0 | €0 | €0 | - |
| Financial fixed assets28 | €9.5m | €9.5m | €9.5m | €9.5m | €10.2m | ▲ 7.9% |
| Current assets29/58 | €5.5m | €6.4m | €6.5m | €7.5m | €7.5m | ▲ 0.2% |
| Amounts receivable after more than one year29 | €0 | €952,875 | €1.6m | €2.3m | €3.0m | ▲ 33.0% |
| Trade receivables290 | €0 | €952,875 | €1.6m | €2.3m | €3.0m | ▲ 33.0% |
| Other amounts receivable291 | €0 | €0 | €0 | €0 | €0 | - |
| Stocks and contracts in progress3 | €954,269 | €1.4m | €1.6m | €1.6m | €1.5m | ▼ 5.7% |
| Stocks30/36 | €954,269 | €1.4m | €1.6m | €1.6m | €1.5m | ▼ 5.7% |
| Contracts in progress37 | €0 | €0 | €0 | €0 | €0 | - |
| Amounts receivable within one year40/41 | €1.7m | €2.4m | €2.8m | €2.2m | €2.3m | ▲ 6.2% |
| Trade receivables40 | €1.2m | €2.3m | €2.3m | €1.7m | €1.5m | ▼ 12.5% |
| Other amounts receivable41 | €495,156 | €149,664 | €464,093 | €512,116 | €855,531 | ▲ 67.1% |
| Current investments50/53 | - | €0 | €0 | €0 | €0 | - |
| Cash at bank and in hand54/58 | €2.8m | €1.6m | €533,599 | €1.3m | €635,010 | ▼ 52.4% |
| Deferred charges and accrued income490/1 | €91,640 | €87,247 | €40,555 | €143,454 | €63,849 | ▼ 55.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €17.8m | €18.8m | €19.6m | €21.0m | €22.4m | ▲ 6.3% |
| Equity10/15 | €12.4m | €13.8m | €15.0m | €16.0m | €17.2m | ▲ 7.4% |
| Contributions10/11 | €6.8m | €6.8m | €6.8m | €6.8m | €6.8m | = |
| Capital10 | €6.8m | €6.8m | €6.8m | €6.8m | €6.8m | = |
| Issued capital100 | €6.8m | €6.8m | €6.8m | €6.8m | €6.8m | = |
| Uncalled capital101 | - | €0 | €0 | €0 | €0 | - |
| Revaluation surpluses12 | €1.2m | €1.2m | €1.2m | €1.2m | €1.2m | = |
| Reserves13 | €926,429 | €791,962 | €581,339 | €399,773 | €441,006 | ▲ 10.3% |
| Non-distributable reserves130/1 | €178,526 | €256,603 | €332,453 | €399,773 | €441,006 | ▲ 10.3% |
| Legal reserve130 | €178,526 | €256,603 | €332,453 | €399,773 | €441,006 | ▲ 10.3% |
| Tax-exempt reserves132 | €747,903 | €535,359 | €248,886 | €0 | - | - |
| Profit (loss) carried forward14 | €2.4m | €4.1m | €5.5m | €6.8m | €7.6m | ▲ 11.6% |
| Investment grants15 | €972,250 | €850,923 | €888,664 | €773,164 | €1.1m | ▲ 47.0% |
| Provisions and deferred taxes16 | €319,483 | €251,755 | €441,153 | €358,790 | €326,124 | ▼ 9.1% |
| Provisions for liabilities and charges160/5 | €70,182 | €73,302 | €358,191 | €358,790 | €326,124 | ▼ 9.1% |
| Pensions and similar obligations160 | €18,182 | €21,302 | €21,302 | €21,901 | €25,874 | ▲ 18.1% |
| Environmental obligations163 | €52,000 | €52,000 | €336,889 | €336,889 | €300,250 | ▼ 10.9% |
| Deferred taxes168 | €249,301 | €178,453 | €82,962 | - | - | - |
| Amounts payable17/49 | €5.1m | €4.8m | €4.1m | €4.7m | €4.8m | ▲ 3.6% |
| Amounts payable after more than one year17 | €2.3m | €1.4m | €682,448 | €227,800 | €1.1m | ▲ 404% |
| Financial debts170/4 | €2.3m | €1.4m | €682,448 | €227,800 | €1.1m | ▲ 404% |
| Amounts payable within one year42/48 | €2.8m | €3.3m | €3.5m | €4.4m | €3.7m | ▼ 16.9% |
| Current portion of amounts payable after more than one year42 | €1.3m | €1.5m | €1.8m | €2.9m | €1.7m | ▼ 40.2% |
| Trade debts44 | €490,909 | €584,823 | €695,770 | €481,394 | €249,077 | ▼ 48.3% |
| Suppliers440/4 | €490,909 | €584,823 | €695,770 | €481,394 | €249,077 | ▼ 48.3% |
| Advances received on contracts in progress46 | - | - | - | - | €110,400 | - |
| Taxes, remuneration and social security45 | €819,864 | €1.1m | €611,363 | €774,052 | €842,533 | ▲ 8.8% |
| Taxes450/3 | €351,822 | €611,739 | €117,957 | €166,642 | €93,110 | ▼ 44.1% |
| Remuneration and social security454/9 | €468,042 | €492,721 | €493,406 | €607,410 | €749,423 | ▲ 23.4% |
| Other amounts payable47/48 | €220,101 | €181,014 | €327,232 | €317,023 | €774,331 | ▲ 144% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €4.8m | €1.5m | €1.2m | €1.1m | €824,661 | ▼ 24.9% |
| + Depreciation and write-downs630 | €1.4m | €771,534 | €624,054 | €829,126 | €1.1m | ▲ 29.3% |
| Operating cash flow (approximation) | €6.2m | €2.3m | €1.9m | €1.9m | €1.9m | ▼ 1.6% |
| Investment in fixed assets (approximation) | - | -€898,325 | -€1.3m | -€1.3m | -€2.4m | ▼ 86.5% |
| Change in cash | - | -€1.2m | -€1.1m | €800,540 | -€699,129 | ▼ 187% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
02-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
09-12
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 497 days late
09-12
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 862 days late
28-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2021
31-12
Financial
Back to profitnet €4.8m
Net result €4.8m after one loss-making year.
31-12
Financial
Equity above €10mEq €12.4m ▲90.6%
Equity rises from €6.5m to €12.4m.
23-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial
Weakest financial yearnet -€1.3m
Net result drops to -€1.3m, the lowest in the series; recovery starts the following year.
10-07
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial
Equity above €5mEq €5.2m ▲9.4%
2 profitable years in a row build equity to €5.2m.
25-06
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
09-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
10-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 30 acts read
About the unread acts
We know of 30 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
30 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Herstal · 1 establishment unit since 2008
Ground area
1.2 ha
Building footprint
4,178 m²
Parcel 62312A0044/00K000, Wallonia. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
KITOZYME
since 20082.176.028.417
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62312A0044/00K000 | Wallonia | 1.2 ha | 1 · 4,178 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
4 owners · 2 holdingsOwners 4
-
44%
-
18.48%
- 18%
- Sourceown accounts 202516%
Holdings 2
-
76%
-
20%
According to the 2025 annual accounts of KITOZYME and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Public money · subsidies and aid
European Union, budget
2024 · 1 entry · 452,495 EUR in total| Year | Entries | awarded |
|---|---|---|
| 2024 | 1 | 452,495 EUR |
Projects
INSIGHT - INTELLIGENT ENCAPSULATION AND SCREENING PLATFORM FOR PRECISION DELIVERY OF PROBIOTICS TO IMPROVE GUT HEALTH
European research
6 projects · 1 as coordinator · 1,158,918 EUR EU contributionProjects
INTELLIGENT ENCAPSULATION AND SCREENING PLATFORM FOR PRECISION DELIVERY OF PROBIOTICS TO IMPROVE GUT HEALTH
Regenerating Bone defects using New biomedical Engineering approaches
A pilot line of antibacterial and antifungal medical textiles based on a sonochemical process
PREvention of Late Stent Thrombosis by an Interdisciplinary Global European effort
The World's first vegetal chitosan biostimulant from non-GMO and renewable source on an industrial scale
Show 1 more projects
TRAINING NETWORK IN INNOVATIVE POLYELECTROLYTES
FOR ENERGY AND ENVIRONMENT
Recognitions · licences · registrations
Food safety, FASFC
1 siteHerstal2.176.028.417
Similar companies · same sector, comparable size
MICHELMAN INTERNATIONAL BELGIUM
BE 0441.566.170
Aubange · Eq €17.5m
SYSTEMHOUSE
BE 0820.144.995
Mouscron · Eq €16.8m
PROVIRON FUNCTIONAL CHEMICALS
BE 0456.889.301
Oostende · Eq €19.2m
integrated DNA technologies
BE 0473.291.407
Leuven · Eq €15.4m
OSTEND BASIC CHEMICALS
BE 0453.390.074
Oostende · Eq €13.6m
Of 106 companies in sector 20140 we hold annual accounts for 93. 58 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded02-01-2001
Fiscal year end31-12
Activities, NACEBEL 2025
20140Manufacture of chemicals and chemical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0473676932
Also
9925:BE0473676932
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.